Skip To Main Content
Misvik Biology Oy on Muck Rack

Misvik Biology Oy

As seen in: Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Misvik Biology

Contact Misvik Biology, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma

|
By Rami Mäkelä, Antti Arjonen, Misvik Biology Oy, Ville Härmä
| Lung Cancer Verified
1. Introduction Thymus is a small gland located beneath breastbone. It is part of the lymph system and plays a key role in adaptive immune system with a function to produce and mature lymphocytes. Thymoma is a subtype of thymic epithelial tumors (TET) originating from the thymic epithelium from thymus gland. Based on the incidence rate of 0.15 cases per 100 000, thymoma is classified as a rare cancer [1x[1]Zucali, P.A., Di Tommaso, L., Petrini, I. et al.
Open in Who Shared Issue with article?
See all 1 articles